



Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
AMID/AIFM2/FSP1 Double Nickase Plasmid (h) | sc-406251-NIC | 20 µg | $410.00 | |||
AMID/AIFM2/FSP1 Double Nickase Plasmid (h2) | sc-406251-NIC-2 | 20 µg | $410.00 |
AIFM2, also known as AMID/FSP1, encodes a flavoprotein oxidoreductase implicated in cellular redox control and stress-response signaling. FSP1 functions as an NAD(P)H-dependent oxidoreductase that suppresses lipid peroxidation by regenerating reduced coenzyme Q, placing it as a key modulator of ferroptosis and membrane oxidative damage. Beyond its antioxidant role, AMID/AIFM2 has been linked to mitochondrial-associated processes and apoptosis-related pathways, with context-dependent effects on cell survival under oxidative stress. Dysregulated FSP1 activity has been associated with cancer biology and resistance to oxidative injury, making AIFM2 a relevant target for mechanistic studies of ferroptosis regulation and redox adaptation.
AMID/AIFM2/FSP1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the AIFM2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within AIFM2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt AIFM2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of AIFM2-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.